Cell And Gene Therapy Videos

  1. Biologics Development At CDMOs Demands More Flexibility 6/11/2025

    Outsourced Pharma Live explored the specific challenges of biologics development that are pushing CDMOs to adopt more flexible approaches. The discussion covered key factors such as customized manufacturing solutions, adaptive project timelines, and responsive technology integration to help ensure that development and manufacturing at CDMOs stay on track in an unpredictable environment.

  2. Flexibility To Meet Your Process Needs 6/11/2025

    Explore a platform that adapts to your evolving workflow through real-world examples of how its flexibility supports diverse inputs, applications, and parameters to ensure consistency, scalability, and efficiency.

  3. Prevent Batch Failures Before They Happen 6/11/2025

    Discover a platform that reduces operator errors and batch failures through automation, real-time monitoring, and intelligent design to ensure greater process reliability and consistent outcomes in your workflow.

  4. Easy Integration Of A New Manufacturing Platform 6/11/2025

    Easily integrate an innovative platform into your manufacturing process with seamless onboarding, regulatory support, and expert guidance that is designed to help you confidently adopt good manufacturing practices.

  5. Deliver What's Next With A Cell Therapy Manufacturing Platform 6/11/2025

    Streamline CAR T cell therapy manufacturing with an end-to-end solution featuring two automated systems that optimize every stage from cell isolation to final therapeutic dose.

  6. Reduce Batch Failure Risk With An Innovative Platform 6/11/2025

    Enhance reliability in cell therapy manufacturing with an innovative platform. Discover how the closed system and automation reduce operator errors through smart monitoring, pre-checks, alarms, and detailed batch reporting.

  7. Increased Productivity At Commercial Scale 6/11/2025

    Discover how a platform that boosts CAR T therapy manufacturing with advanced automation and modular design reduces labor, increases scalability, and enhances productivity for efficient commercial-scale production.

  8. Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery 6/3/2025

    Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.

  9. The Advantages Of Off-The-Shelf GMP iPSCs With A DMF 6/2/2025

    Learn how off-the-shelf, GMP-grade iPSC lines with a Drug Master File (DMF) can accelerate cell therapy development, streamline regulatory approval, and reduce time and cost to clinic.

  10. Key Considerations For Cell Therapy Outsourcing 5/29/2025

    During a recent Outsourced Pharma Live, one of our speakers provided some key points to consider if you are a cell-therapy organization relying on CDMOs.